Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (9)

Search Parameters:
Keywords = Kadish

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
9 pages, 1146 KiB  
Case Report
Hairy Cell Leukemia: A Differential Diagnosis of Hepatitis B-Associated Aplastic Anemia and Syphilis
by I. Kindekov, E. Beleva, M. Kadish, I. Ionchev and N. Semerdzhieva
Hematol. Rep. 2025, 17(2), 13; https://doi.org/10.3390/hematolrep17020013 - 15 Mar 2025
Viewed by 698
Abstract
Aplastic anemia occurs with an incidence of 2–5: 1 million people worldwide. However, the frequency of newly diagnosed cases of bone marrow aplasia is greater, and some of these patients present to emergency departments initially. Description of Case: We present the case of [...] Read more.
Aplastic anemia occurs with an incidence of 2–5: 1 million people worldwide. However, the frequency of newly diagnosed cases of bone marrow aplasia is greater, and some of these patients present to emergency departments initially. Description of Case: We present the case of a middle-aged man with pancytopenia. In this case, aplastic anemia associated with hepatitis B and syphilis was only the initial diagnosis. An indolent hematologic malignancy—hairy cell leukemia—was diagnosed as the real cause of the bone marrow failure in a clinic of hematology. Conclusions: This clinical case allows us to make a conclusion, albeit not definitively, about the contribution of hepatitis B and syphilis to the clinical manifestation of hairy cell leukemia. A detailed and consistent diagnostic plan is also required in patients presenting with pancytopenia. Failure to diagnose a hepatitis B infection in a patient with malignant hematologic disease would lead to fatal therapeutic errors. Full article
Show Figures

Figure 1

20 pages, 2224 KiB  
Review
The Role of Artificial Intelligence in the Identification and Evaluation of Bone Fractures
by Andrew Tieu, Ezriel Kroen, Yonaton Kadish, Zelong Liu, Nikhil Patel, Alexander Zhou, Alara Yilmaz, Stephanie Lee and Timothy Deyer
Bioengineering 2024, 11(4), 338; https://doi.org/10.3390/bioengineering11040338 - 29 Mar 2024
Cited by 16 | Viewed by 4045
Abstract
Artificial intelligence (AI), particularly deep learning, has made enormous strides in medical imaging analysis. In the field of musculoskeletal radiology, deep-learning models are actively being developed for the identification and evaluation of bone fractures. These methods provide numerous benefits to radiologists such as [...] Read more.
Artificial intelligence (AI), particularly deep learning, has made enormous strides in medical imaging analysis. In the field of musculoskeletal radiology, deep-learning models are actively being developed for the identification and evaluation of bone fractures. These methods provide numerous benefits to radiologists such as increased diagnostic accuracy and efficiency while also achieving standalone performances comparable or superior to clinician readers. Various algorithms are already commercially available for integration into clinical workflows, with the potential to improve healthcare delivery and shape the future practice of radiology. In this systematic review, we explore the performance of current AI methods in the identification and evaluation of fractures, particularly those in the ankle, wrist, hip, and ribs. We also discuss current commercially available products for fracture detection and provide an overview of the current limitations of this technology and future directions of the field. Full article
(This article belongs to the Section Biosignal Processing)
Show Figures

Figure 1

11 pages, 1078 KiB  
Article
Recurrent Esthesioneuroblastoma: Long-Term Outcomes of Salvage Therapy
by Garrett Ni, Carlos D. Pinheiro-Neto, Ehiremen Iyoha, Jamie J. Van Gompel, Michael J. Link, Maria Peris-Celda, Eric J. Moore, Janalee K. Stokken, Mauricio Gamez and Garret Choby
Cancers 2023, 15(5), 1506; https://doi.org/10.3390/cancers15051506 - 28 Feb 2023
Cited by 12 | Viewed by 2822
Abstract
Introduction: Esthesioneuroblastoma (ENB) is a rare malignant neoplasm arising from the olfactory epithelium of the cribriform plate. Although survival is excellent with a reported 5-year overall survival (OS) of 82%, recurrence is frequent and occurs in 40–50% of cases. This study investigates the [...] Read more.
Introduction: Esthesioneuroblastoma (ENB) is a rare malignant neoplasm arising from the olfactory epithelium of the cribriform plate. Although survival is excellent with a reported 5-year overall survival (OS) of 82%, recurrence is frequent and occurs in 40–50% of cases. This study investigates the characteristics of ENB recurrence and the subsequent prognosis of patients with recurrence. Methods: The clinical records of all patients diagnosed as having ENB with subsequent recurrence at a tertiary hospital from 1 January 1960 to 1 January 2020 were retrospectively reviewed. Overall survival (OS) and progression-free survival (PFS) were reported. Results: A total of 64 out of 143 ENB patients had recurrences. In total, 45 out of 64 recurrences met the inclusion criteria and were included in this study. From these, 10 (22%) had a sinonasal recurrence, 14 (31%) had an intracranial recurrence, 15 (33%) had a regional recurrence, and 6 (13%) had a distal recurrence. The average interval from initial treatment to recurrence was 4.74 years. There were no differences in rates of recurrence with respect to age, sex, or types of surgery (endoscopic, transcranial, lateral rhinotomy, and combined). The time to recurrence was shorter for Hyams grades 3 and 4 compared to Hyams grades 1 and 2 (3.75 years vs. 5.70 years, p < 0.05). Patients with recurrence limited to the sinonasal region had a lower overall primary Kadish stage compared to recurrences beyond the sinonasal region (2.60 vs. 3.03, p < 0.05). A total of 9 (20%) out of 45 patients developed secondary recurrence. Following recurrence, the subsequent 5-year OS and PFS were 63 and 56%, respectively. The mean time to secondary recurrence after treatment of the primary recurrence was 32 months, which was significantly shorter than the time to primary recurrence (32 months vs. 57 months, p = 0.048). The mean age of the secondary recurrence group is significantly older than the primary recurrence group (59.78 years vs. 50.31 years, p = 0.02). No statistically significant differences were observed between the secondary recurrence group and the recurrence group in terms of their overall Kadish stages or Hyams grades. Conclusions: Following an ENB recurrence, salvage therapy appears to be an effective therapeutic option with a subsequent 5-year OS of 63%. However, subsequent recurrences are not infrequent and may require additional therapy. Full article
(This article belongs to the Special Issue Skull Base Tumors)
Show Figures

Figure 1

13 pages, 2275 KiB  
Article
Olfactory Neuroblastomas: What Actually Happens in the Long-Term?
by Konstantinos Mantsopoulos, Michael Koch, Heinrich Iro and Jannis Constantinidis
J. Clin. Med. 2022, 11(9), 2288; https://doi.org/10.3390/jcm11092288 - 20 Apr 2022
Cited by 3 | Viewed by 3486
Abstract
Objective: The aim of this study was to investigate the long-term oncologic outcome and review the state of the art in the management of olfactory neuroblastomas. Material and Methods: The records of all patients treated for olfactory neuroblastomas in two academic departments between [...] Read more.
Objective: The aim of this study was to investigate the long-term oncologic outcome and review the state of the art in the management of olfactory neuroblastomas. Material and Methods: The records of all patients treated for olfactory neuroblastomas in two academic departments between 1975 and 2012 were evaluated retrospectively. Data on epidemiological parameters were collected (age, gender), along with staging (Kadish, Morita), histologic grading (Hyams), time and form of treatment, locoregional control, and disease-specific and overall survival. Patients with other malignant diseases, distant metastases of olfactory neuroblastomas at the time of initial diagnosis, a follow-up time of less than 5 years, or insufficient clinical-pathological data were excluded from further analysis. Results: In total, 53 cases made up our final study sample (26 men, 27 women; male–female ratio 0.96:1). Their mean age was 48.6 years (range: 10–84 years). The mean follow-up time was 137.5 months (4–336 months, SD: 85.0). A total of 5 out of 53 study cases (9.4%) showed metastatic involvement of the neck at the time of initial presentation. Local recurrence was detected in 8/53 (15.1%) and regional recurrence in 7/53 of our study cases (13.2%). Three patients (42.8%) from the group of cases with surgery as the sole form of management (7/53, 13.2%) died due to the disease. The cumulative disease-specific survival and overall survivalfor the whole group of patients were 88.6% and 63.6%, respectively. The cumulative disease-specific survival stratified by Kadish A/B vs. Kadish C/D as well as Hyams I/II vs. Hyams III/IV showed superior results for limited tumors, albeit without significance, and low-grade tumors (highly significant difference). Conclusion: Craniofacial or sometimes solely endoscopically controlled resection can warrant resection of the olfactory neuroblastoma with wide margins. However, locoregional failures and distant metastases can occur after a long period of time. The non-negligible incidence of regional recurrences, partly in unusual localizations, leads us to consider the need to identify the “recurrence-friendly” cases and to perform individualized elective irradiation of the neck in cases with high-risk features. Full article
(This article belongs to the Special Issue Head and Neck Surgery: Clinical Updates and Perspectives)
Show Figures

Figure 1

15 pages, 3772 KiB  
Article
Computer Vision-Based Classification of Flow Regime and Vapor Quality in Vertical Two-Phase Flow
by Shai Kadish, David Schmid, Jarryd Son and Edward Boje
Sensors 2022, 22(3), 996; https://doi.org/10.3390/s22030996 - 27 Jan 2022
Cited by 11 | Viewed by 4059
Abstract
This paper presents a method to classify flow regime and vapor quality in vertical two-phase (vapor-liquid) flow, using a video of the flow as the input; this represents the first high-performing and entirely camera image-based method for the classification of a vertical flow [...] Read more.
This paper presents a method to classify flow regime and vapor quality in vertical two-phase (vapor-liquid) flow, using a video of the flow as the input; this represents the first high-performing and entirely camera image-based method for the classification of a vertical flow regime (which is effective across a wide range of regimes) and the first image-based tool for estimating vapor quality. The approach makes use of computer vision techniques and deep learning to train a convolutional neural network (CNN), which is used for individual frame classification and image feature extraction, and a deep long short-term memory (LSTM) network, used to capture temporal information present in a sequence of image feature sets and to make a final vapor quality or flow regime classification. This novel architecture for two-phase flow studies achieves accurate flow regime and vapor quality classifications in a practical application to two-phase CO2 flow in vertical tubes, based on offline data and an online prototype implementation, developed as a proof of concept for the use of these models within a feedback control loop. The use of automatically selected image features, produced by a CNN architecture in three distinct tasks comprising flow-image classification, flow-regime classification, and vapor quality prediction, confirms that these features are robust and useful, and offer a viable alternative to manually extracting image features for image-based flow studies. The successful application of the LSTM network reveals the significance of temporal information for image-based studies of two-phase flow. Full article
(This article belongs to the Topic Artificial Intelligence in Sensors)
Show Figures

Figure 1

12 pages, 3053 KiB  
Article
Preparation of Deuterium Labeled Compounds by Pd/C-Al-D2O Facilitated Selective H-D Exchange Reactions
by Anne Kokel, Dora Kadish and Béla Török
Molecules 2022, 27(3), 614; https://doi.org/10.3390/molecules27030614 - 18 Jan 2022
Cited by 6 | Viewed by 5072
Abstract
The chemo/regioselective H-D exchange of amino acids and synthetic building blocks by an environmentally benign Pd/C-Al-D2O catalytic system is described. Due to the importance of isotope labeled compounds in medicinal chemistry and structural biology, notably their use as improved drug candidates [...] Read more.
The chemo/regioselective H-D exchange of amino acids and synthetic building blocks by an environmentally benign Pd/C-Al-D2O catalytic system is described. Due to the importance of isotope labeled compounds in medicinal chemistry and structural biology, notably their use as improved drug candidates and biological probes, the efficient and selective deuteration methods are of great interest. The approach is based on selective H-D exchange reactions where the deuterium source is simple D2O. D2 gas is generated in situ from the reaction of aluminum and D2O, while the commercially available palladium catalyst assists the H-D exchange reaction. The high selectivity and efficiency, as well as the simplicity and safe nature of the procedure make this method an environmentally benign alternative to current alternatives. Full article
(This article belongs to the Special Issue Organic Chemistry in the USA)
Show Figures

Figure 1

18 pages, 1670 KiB  
Review
A Multilingual Integrative Review of Health Literacy in Former Soviet Union, Russian-Speaking Immigrants
by Uliana Kostareva, Cheryl L. Albright, Eva-Maria Berens, Patricia Polansky, Deborah E. Kadish, Luba L. Ivanov and Tetine L. Sentell
Int. J. Environ. Res. Public Health 2021, 18(2), 657; https://doi.org/10.3390/ijerph18020657 - 14 Jan 2021
Cited by 9 | Viewed by 5028
Abstract
Large diasporas of former Soviet Union (FSU) immigrants are found in the USA, Germany, and Israel. To synthesize evidence, identify limitations, and propose future directions we conducted an integrative review on the health literacy of FSU immigrants, migrants, or refugees in four languages. [...] Read more.
Large diasporas of former Soviet Union (FSU) immigrants are found in the USA, Germany, and Israel. To synthesize evidence, identify limitations, and propose future directions we conducted an integrative review on the health literacy of FSU immigrants, migrants, or refugees in four languages. Following integrative review and PRISMA guidelines, we searched four databases in English and performed supplementary searches in Russian, German, and Hebrew to identify qualitative and quantitative studies on FSU immigrants and health literacy. Six articles met inclusion criteria in English and one in German; the majority were published in the last five years. Only two articles measured health literacy of FSU immigrants, which was lower than the general population. Four articles were about immigrants with a mean age ≥50 years. All articles stressed the value of translated, culturally relevant health information. The health literacy of FSU immigrants is understudied, despite clear needs. Future research should include assessments of FSU immigrants’ health literacy and include diverse (e.g., age, gender) yet well-defined populations to determine both barriers and facilitators to their health literacy. This review, an example of a multilingual search, provided a comprehensive understanding of existing literature and is a useful approach for global health literacy research. Full article
(This article belongs to the Collection Global Health Literacy)
Show Figures

Figure 1

11 pages, 3398 KiB  
Article
Advanced Radiation Techniques in the Treatment of Esthesioneuroblastoma: A 7-Year Single-Institution’s Clinical Experience
by Jakob Liermann, Mustafa Syed, Thomas Held, Denise Bernhardt, Peter Plinkert, Christine Jungk, Andreas Unterberg, Stefan Rieken, Jürgen Debus, Klaus Herfarth and Sebastian Adeberg
Cancers 2018, 10(11), 457; https://doi.org/10.3390/cancers10110457 - 20 Nov 2018
Cited by 14 | Viewed by 5166
Abstract
(1) Background: Esthesioneuroblastoma (ENB) is a rare tumor entity originating from the olfactory neuroepithelium. There is a scarcity of data about different treatment strategies. Intensity modulated radiotherapy (IMRT) and carbon ion radiotherapy (CIRT) are advanced radiation techniques that might improve local tumor control. [...] Read more.
(1) Background: Esthesioneuroblastoma (ENB) is a rare tumor entity originating from the olfactory neuroepithelium. There is a scarcity of data about different treatment strategies. Intensity modulated radiotherapy (IMRT) and carbon ion radiotherapy (CIRT) are advanced radiation techniques that might improve local tumor control. (2) Methods: This retrospective analysis contained 17 patients with ENB (Kadish stage ≥ C: 88%; n = 15). Four patients had already undergone previous radiotherapy (RT). The treatment consisted of either IMRT (n = 5), CIRT (n = 4) or a combination of both techniques (n = 8). Median follow-up was 29 months. (3) Results: In patients that had not been irradiated before (n = 13), calculated overall survival (OS) and progression free survival (PFS) rates after 48 months were 100% and 81% respectively (Kaplan-Meier estimates). Two of four patients that underwent reirradiation died after RT, presumably due to tumor progression. Besides common toxicities, five patients (30%) showed mostly asymptomatic radiation-induced brain changes, most likely due to a disturbance of the blood-brain barrier. (4) Conclusions: Our results demonstrate that IMRT, CIRT, a combined approach of IMRT and CIRT as well as reirradiation with CIRT seem to be feasible and effective treatment methods in ENB. Full article
(This article belongs to the Special Issue New Developments in Radiotherapy)
Show Figures

Figure 1

16 pages, 1091 KiB  
Article
Polyethylene Glycol Exposure with Antihemophilic Factor (Recombinant), PEGylated (rurioctocog alfa pegol) and Other Therapies Indicated for the Pediatric Population: History and Safety
by Reinhard Stidl, Michael Denne, Jimena Goldstine, Bill Kadish, Katherine I. Korakas and Peter L. Turecek
Pharmaceuticals 2018, 11(3), 75; https://doi.org/10.3390/ph11030075 - 26 Jul 2018
Cited by 20 | Viewed by 10034
Abstract
Polyethylene glycol (PEG) is an inert, water soluble polymer, used for decades in pharmaceuticals. Although PEG is considered safe, concerns persist about the potential adverse effects of long-term exposure to PEG-containing therapies, specifically in children, following the introduction of PEGylated recombinant factor products [...] Read more.
Polyethylene glycol (PEG) is an inert, water soluble polymer, used for decades in pharmaceuticals. Although PEG is considered safe, concerns persist about the potential adverse effects of long-term exposure to PEG-containing therapies, specifically in children, following the introduction of PEGylated recombinant factor products used for the treatment of hemophilia. Given the absence of long-term surveillance data, and to evaluate the potential risk, we estimated PEG exposure in the pediatric population receiving PEGylated therapies with pediatric indications administered intravenously or intramuscularly. We used a range of pediatric weights and doses based on prescribing information (PI) or treatment guidelines. PIs and reporting websites were searched for information about adverse events (AEs). For a child weighing 50 kg on the highest prophylactic dose of a FVIII product, the range of total PEG exposure was 40–21,840 mg/year; for factor IX (FIX) products, the range was 13–1342 mg/year; and for other products, the range was 383–26,743 mg/year, primarily as a derivative excipient. No AE patterns attributable to PEG were found for any of these products, including potential renal, neurological, or hepatic AEs. Our analyses suggest the pediatric population has had substantial exposure to PEG for several decades, with no evidence of adverse consequences. Full article
(This article belongs to the Special Issue Polyethylene Glycol (PEG) and PEGylation in Pharmacy)
Show Figures

Figure 1

Back to TopTop